Researcher
Petersohn, S.
PhD, Researcher (MUMC)
View graph of relations
- 2019
- PublishedGrimm, S. E., Fayter, D., Ramaekers, B. L. T., Petersohn, S., Riemsma, R., Armstrong, N., ... Joore, M. A. (2019). Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 37(10), 1195-1207. https://doi.org/10.1007/s40273-019-00792-7
- PublishedPetersohn, S., Ramaekers, B. L. T., Olie, R. H., ten Cate-Hoek, A. J., Daemen, J-W. H. C., ten Cate, H., & Joore, M. A. (2019). Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments. Quality of Life Research, 28(8), 2257-2279. https://doi.org/10.1007/s11136-019-02166-0
- PublishedGrimm, S. E., Armstrong, N., Ramaekers, B. L. T., Pouwels, X., Lang, S., Petersohn, S., ... Joore, M. A. (2019). Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 37(5), 655-667. https://doi.org/10.1007/s40273-018-0723-5